References, Ethics and Privacy
Ethics"Immunosuppression screen - a risk management tool for patients" has been reviewed and approved by the Sydney South West Area Health Service Human Research Ethics Commitee - CRGH Zone: Protocol number: CH62/6/2011-007 - S. Riminton.
Privacy"Immunosuppression screen - a risk management tool for patients" collects no identifying personal information and does not require patient consent.
Reference InformationImmunosuppression Screen
Riminton DS et al, Managing the risks of Immunosuppression. Current Opinion in Neurology, 2011, 24: 217-223 http://www.ncbi.nlm.nih.gov/pubmed/21519254
Cardiovascular Risk Calculator
The screening tool uses information from the "New Zealand Cardiovascular Risk Calculator"
Hoes JN, et al. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2007; 66:1560�1567.
World Health Organization
Rahier JF et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology 2010, 49, 1815-1827